Edward R Damiano

This inventor holds 60 USPTO granted patents and 31 published patent applications, plus 7 CIPO patents and 10 EPO patents, primarily in Glucose Control Systems (CPC class A61M). Top assignees: Beta Bionics, Inc., Boston University, The General Hospital Corporation. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward R Damiano. Retrieved from https://idiyas.com/inventor/edward-r-damiano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 60 (Patent Applications = 31)

% Patents Active = 100.0

CIPO Patents = 7 (Patent Applications = 6)

EPO Patents = 10 (Patent Applications = 14)

Average Co-Inventor Count = 3.7

ph-index = 14

Forward Citations = 670(Granted Patents)

Forward Citations (Not Self Cited) = 261(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

The General Hospital Corporation

patents

4. 1 out of 2,430

University of Illinois

patents

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Glucose Control

Infusion Device

Ambulatory Medicament

Therapy Customization

Automated Adaptation

Alarm System

Data Access Management

Cloud-Connected Pump

Graphical User Interface

Dose Control

Patient Safety

Carbohydrate Therapy

60 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12743269 - Ambulatory medical device with malfunction alert prioritization (2026-09-22),

2. 12465686 - Emergency medicament dose control (2025-11-11),

3. 12280241 - Glucose control system with automatic adaptation of glucose target (2025-04-21),

4. 12204889 - Ambulatory medicament device alarm system (2025-01-21),

5. 12201803 - Infusion system and components thereof (2025-01-21),

6. 12093681 - Ambulatory medicament device with security override passcode (2024-09-17),

7. RE50080 - Blood glucose control system (2024-08-20),

8. RE50075 - Glucose level control system with offline control based on preceding periods of online control (2024-08-13),

9. D1032624 - Display screen with animated graphical user interface (2024-06-25),

10. D1032623 - Display screen with animated graphical user interface (2024-06-25),

11. D1031975 - Medicament infusion pump device (2024-06-18),

12. 11957876 - Glucose control system with automated backup therapy protocol generation (2024-04-16),

13. D1022185 - Medicament infusion pump device (2024-04-09),

14. 11941392 - Ambulatory medical device with malfunction alert prioritization (2024-03-26),

15. 11803367 - Ambulatory medicament device with alarm (2023-10-31),

Title: The Pioneering Innovations of Edward R Damiano in Medical Technology

Introduction: Edward R Damiano, a visionary inventor based in Acton, MA (US), has made remarkable contributions to the field of medical technology. With a total of 49 patents to his name, Damiano's work exemplifies his passion for creating innovative solutions that have the potential to transform and save lives.

Latest Patents: One of Damiano’s latest patents is the "Glucose control system with automated backup therapy protocol generation." This groundbreaking automated blood glucose control system is designed to generate a backup therapy protocol consisting of insulin therapy instructions derived from autonomously determined doses of insulin. The system uses a sophisticated control algorithm to determine the appropriate insulin doses to control the subject's blood glucose levels, based on real-time data from a glucose sensor. It also tracks and records the insulin therapy administered over a specific period, providing valuable insights for generating backup therapy protocols.

Career Highlights: Edward R Damiano has been associated with leading companies in the medical technology sector, including Beta Bionics, Inc. and Boston University. His innovative mindset and expertise have led to significant advancements in the development of cutting-edge medical devices aimed at enhancing the quality of life for individuals with diabetes.

Collaborations: Throughout his career, Damiano has collaborated with accomplished professionals in the field of medical technology. Notable coworkers include Firas H El-Khatib and Michael J Rosinko, who have worked alongside Damiano to bring his innovative ideas to fruition.

Conclusion: Edward R Damiano's pioneering innovations in medical technology underscore his commitment to improving healthcare outcomes through groundbreaking inventions. His relentless dedication to creating novel solutions for managing diabetes has positioned him as a trailblazer in the field, with his work continuing to have a profound impact on countless lives worldwide.

Profile summary based on public USPTO records.